- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: LCZ696
Total 78 results
-
Novartis PharmaceuticalsCompletedEssential HypertensionTaiwan, Japan, Hong Kong, Thailand, Philippines, China, Korea, Republic of
-
Novartis PharmaceuticalsCompletedChronic Heart FailurePoland, Netherlands, United States, Argentina, Spain, Singapore, Italy, India, Russian Federation, Canada, Romania, Brazil, Venezuela, Germany
-
Novartis PharmaceuticalsCompletedEssential HypertensionUnited States
-
Novartis PharmaceuticalsCompletedHypertensionSpain, Italy, Netherlands, United States, Denmark, Taiwan, Argentina, Germany, Russian Federation, Slovakia, Canada, Hungary, Latvia, Lithuania, Poland, Finland, France, Sweden
-
Novartis PharmaceuticalsWithdrawnPost Myocardial Infarction
-
Novartis PharmaceuticalsCompletedHeart FailureUnited States
-
Novartis PharmaceuticalsCompletedCardiomyopathy, HypertrophicUnited States, Germany, United Kingdom, Spain, Korea, Republic of, Greece
-
Novartis PharmaceuticalsCompletedSystolic HypertensionUnited States, Spain, Hungary, Korea, Republic of, Argentina, India, Slovakia, Canada, Romania
-
Novartis PharmaceuticalsCompletedHeart Failure With Preserved Ejection Fraction (HFpEF)United States, Canada
-
LanZhou UniversityRecruiting
-
Duke UniversityNovartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedHypertensionUnited States, Colombia, Spain, Germany, Taiwan, Russian Federation, Argentina, France, Italy, Korea, Republic of, Japan, Greece
-
Novartis PharmaceuticalsCompletedMild to Moderate HypertensionGermany
-
University of ZurichNovartis PharmaceuticalsCompleted
-
Guangdong Provincial People's HospitalUnknownHeart Failure | Hemodialysis ComplicationChina
-
Novartis PharmaceuticalsTerminatedHeart Failure With Reduced Ejection FractionChina, Germany, United States, Colombia, Korea, Republic of, Romania, South Africa, Canada, Belgium, Estonia, Hungary, Italy, Russian Federation, Taiwan, Turkey, United Kingdom, Spain, France, Netherlands, Hong Kong, Bulgaria, Israel and more
-
Novartis PharmaceuticalsCompletedEssential HypertensionTaiwan, Japan, Philippines, China, Korea, Republic of, Malaysia
-
Advanced Accelerator ApplicationsRecruitingNeoplasmsUnited States, Netherlands, Austria, Spain, France, Germany, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingHeart Failure | Chagas DiseaseBrazil, Argentina, Mexico, Colombia
-
Minneapolis Heart Institute FoundationAbbott Medical DevicesCompleted
-
Novartis PharmaceuticalsCompletedHypertension | Concurrent ObesityGermany, Netherlands
-
Brigham and Women's HospitalNovartis PharmaceuticalsWithdrawnHeart Failure With Reduced Ejection Fraction
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type II
-
Novartis PharmaceuticalsCompletedEssential HypertensionChina, Taiwan, Japan, Thailand, Korea, Republic of
-
Centre Hospitalier de PAUUniversity Hospital, BordeauxCompletedNervous System Diseases | Multiple Sclerosis, Chronic ProgressiveFrance
-
Procter and GambleCompleted
-
Vanderbilt University Medical CenterActive, not recruitingHypertensionUnited States
-
University of NebraskaNational Cancer Institute (NCI); Genta IncorporatedTerminatedStage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma | Stage I Adult Diffuse Large Cell LymphomaUnited States